Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Searches
(0)
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Online First
Supplements
NCCN Meeting Highlights
JNCCN In the News
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
Volume 9 (2011): Issue Suppl_3 (Feb 2011): NCCN Oncology Pharmacy & Policy
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
Citation Alert
New NCCN Program Recognizes Organizations Supporting Coverage for Clinical Trials and Appropriate Off-Label Drug Usage
Pages: vii–ix
NCCN Trends
Pages: x
Take Your Medicine
By:
Harold J. Burstein
Pages: S-1
A Quick REMS Update and a Clinical Focus
By:
Edward C. Li
Pages: S-2–S-3
Informing Patients: Translating the NCCN Guidelines
By:
Joan S. McClure
Pages: S-4–S-5
Biosimilars: Approval and Acceptance?
By:
Jessica K. DeMartino
Pages: S-6–S-9
Where Your Data Is Going and Where It's Been
By:
Jane M. Quigley
Pages: S-10–S-12
New Options for the Management of Castration-Resistant Prostate Cancer: A Case Perspective
By:
Dawn Goetz
Pages: S-13–S-24
Pharmacotherapy for Chronic Myelogenous Leukemia: A Case-Based Approach
By:
Stephen Harnicar
Pages: S-25–S-35
Safe and Successful Implementation of CPOE for Chemotherapy at a Children's Cancer Center
By:
James M. Hoffman
,
Donald K. Baker
,
Scott C. Howard
,
Joseph H. Laver
and
Jerry L. Shenep
Pages: S-36–S-50
Collapse
Expand
Search
Issue
Journal
[3.227.235.183]
3.227.235.183
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save